The benefits of Cannabinoids – THC, THCV, THV & CBN/CBD
Cannabinoids are a unique variety of chemical compounds only found in the marijuana plant and the human body/animals. Plant cannabinoids are called phytocannabinoids and in humans they are called endocannabinoids. When these two compounds bind, research has found and continues to discover several health benefits.
THC- Delta-9-tetrahydrocannabinol: Euphoric, stimulant, muscle relaxant, anti-epileptic, anti-emetic, anti-inflammatory, appetite stimulating, bronchio-dilating, hypotensive, anti-depressant and analgesic effects.
THCV, THV – Tetrahydrocannabivarin, also known as tetrahydrocannabivarol:
A non-psychoactive cannabinoid found naturally in Cannabis sativa. It is an analogue of tetrahydrocannabinol (THC) with the sidechain shortened by two CH2 groups. THCV can be used as a marker compound to differentiate between the consumption of hemp products and synthetic THC (e.g., Marinol). THCV is found in largest quantities in Cannabis sativa subsp. sativa strains. Some varieties that produce propyl cannabinoids in significant amounts, over five percent of total cannabinoids, have been found in plants from South Africa, Nigeria, Afghanistan, India, Pakistan and Nepal with THCV as high as 53.69% of total cannabinoids. They usually have moderate to high levels of both THC and Cannabidiol (CBD) and hence have a complex cannabinoid chemistry representing some of the world’s most exotic cannabis varieties. It has been shown to be a CB1 receptor antagonist, i.e. blocks the effects of THC. In 2007 GW Pharmaceuticals announced that THCV is safe in humans in a clinical trial and it will continue to develop THCV as a potential cannabinoid treatment for type 2 diabetes and related metabolic disorders, similar to the CB1 receptor antagonist rimonabant.
CBD – Cannabidiol:
A major constituent of medical cannabis. CBD represents up to 40% of extracts of the medical cannabis plant. Cannabidiol relieves convulsion, inflammation, anxiety, nausea, and inhibits cancer cell growth. Recent studies have shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia. In November 2007 it was reported that CBD reduces growth of aggressive human breast cancer cells in vitro and reduces their invasiveness. It thus represents the first non-toxic exogenous agent that can lead to down-regulation of tumor aggressiveness. It is also a neuroprotective antioxidant. Also lessens the psychoactive effects of THC and has sedative and analgesic effects.
CBC – Cannabichromene:
Promotes the effects of THC and has sedative and analgesic effects.
CBG – Cannabigerol:
Has sedative effects and anti-microbial properties as well as lowering intra-ocular pressure. CBG is the biogenetic precursor of all other cannabinoids.
CBN – Cannabinol :
A mildly psychoactive degradation of THC, it’s primary effects are as an anti-epileptic, and to lower intra-ocular pressure.
Cannibas strains are know to help relieve the following symptoms.
• Pain from various ailments and injuries
• Arthritis, bursitis
• Multiple sclerosis
• Hepatitis C
• Nausea and low appetite
• Cancer, chemotherapy
• Muscular dystrophy
• Epilepsy, parkinson’s
• Asthma, emphysema
• Glaucoma and other intra-ocular disorders
• Skin diseases such as pruritis and psoriasis
• Back pain and muscle spasms
• Paraplegia and quadriplegia
• Insomnia and other sleep disorders
• Study finds THC promotes death of brain cancer cells and shrinks tumors *